Exhibit 8.1
Private and confidential | 25 October 2021 |
Evaxion Biotech A/S | |
Dr. Neergaardsvej 5F | |
DK-2970 Hørsholm | |
Denmark | |
Opinion regarding the registration with the US Securities and Exchange Commission of American Depositary Shares representing ordinary shares in the share capital of Evaxion Biotech A/S
Ladies and Gentlemen:
Acting in the capacity of Danish tax advisor to Evaxion Biotech A/S (the “Issuer”) we have prepared this opinion in accordance with the requirements of Item 601(b)(8) of Regulation S-K on the Registration Statement on form F-1 dated 26 October 2021 to be filed with the US Securities and Exchange Commission of American Depositary Shares representing ordinary shares in the share capital of the Issuer.
Scope and limitation
In this opinion we express no other opinion as to any matter pertaining to the contents of the Registration Statement or related documents other than expressly stated below.
For the purpose of the opinion we have examined the section “Taxation - Danish Tax Consideration” on page 245 to 249 of the Registration Statement. We have further relied upon the assumptions and the accuracy of the factual statements made in the Registration Statement.
We have based our opinion solely on Danish law, regulations, and administrative and judicial interpretations in force as of the date of this opinion and we express no opinion with regards to the laws of any other jurisdiction than Denmark.
Opinion
Based upon the foregoing scope, assumptions and limitations stated herein we are of the opinion that the statements made in the Registrations Statements under the caption “Taxation – Danish Tax Considerations” from page 247 to 251 insofar they purport to constitute summaries of certain provisions under Danish tax law, constitute accurate summaries of such matters in all material aspect.